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Lateral hypothalamic neuropeptides, orexins, have been recognized as one of the most 
important regulators of sleep/wakefulness states. Besides, these peptides are also 
regarded as an important factor that regulates feeding behavior, owing to their 
localization within the lateral hypothalamic area, the classic “feeding center”, 
pharmacological activities, and the fact that prepro-orexin mRNA is upregulated when 
animals are fasted. This review summarizes the role of orexins in the regulation of 





Orexins are hypothalamic neuropeptides identified in 19981. Several studies showed 
that orexin deficiency causes narcolepsy in humans and animals, implicating these 
hypothalamic neuropeptides in play a critical role in the regulation of sleep/wakefulness 
states2-6. However, orexins were initially recognized as regulators of feeding behavior, 
firstly because of their exclusive production in the lateral hypothalamic area (LHA), a 
region known as the “feeding center”, and secondly because of their pharmacological 
activity; intracerebroventricular (ICV) injection of orexins induced feeding behavior in 
rats and mice1,7-9.  Recent studies suggested that further orexins play further roles in 
the coordination of emotion, energy homeostasis, reward system, drug addiction, and 
arousal10-17. This review focuses especially on the role of orexins in the regulation of 
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feeding, body weight and energy homeostasis in relation to other systems in which 
orexins are shown to be involved (Fig. 1). 
 
1.Overview of the orexin system 
1-1.Orexins and their structures 
In 1998, we identified novel neuropeptides, orexin A and orexin B, from rat brain 
extracts as two endogenous ligands for two orphan G-protein-coupled receptors by a 
method so-called "reverse pharmacology", which utilized receptor-expressing cell lines 
as the assay system1. Molecular cloning studies showed that both orexin A and orexin B 
are derived from a common precursor peptide, prepro-orexin. An mRNA encoding the 
same precursor peptide was independently identified by de Lecea et al. as a 
hypothalamus-specific transcript18.  de Lecea et al. predicted that the transcript 
encoded a polypeptide precursor that is proteolytically cleaved to produce two 
isopeptides, and named them as hypocretin-1 and hypocretin-2 (corresponding to orexin 
A and orexin B, respectively).   
Orexin A and orexin B constitute a novel distinct peptide family, showing no 
significant homology with any other peptides19.  Structural analysis of purified peptide 
showed that orexin A is a 33-amino-acid peptide with an N-terminal pyroglutamyl 
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residue, two intra-chain disulfide bonds, and C-terminal amidation. This structure is 
completely conserved among mammalian species (human, rat, mouse, cow, sheep, dog 
and pig).  Orexin B is a 28-amino-acid, C-terminally amidated linear peptide. Amino 
acid sequences of various species of orexin B show that there are several inter-species 
differences, although highly conserved. The C-terminal half of orexin B is very similar 
to that of orexin A, whereas the N-terminal half is more variable.  
 
1-2 Transcriptional regulation of orexin 
Prepro-orexin mRNA is highly specifically expressed by a population of neurons which 
are located in and around the LHA1,20. The expression of orexin has been shown to be 
upregulated by fasting1, suggesting that the transcriptional regulatory sytem of orexin 
gene should include the mechanisms that restrict the expression of orexin mRNA in a 
selective population of neurons in the LHA, and that increase its expression during 
fasting. However, very limited information has been available to elucidate these 
mechanisms so far.  
The 3.2-kb 5'-flanking region of the human prepro-orexin gene is sufficient for 
the specific expression in orexin neurons20,21, and thus has been used as a promoter to 
drive specific expression in orexin neurons. We found two phylogenetically conserved 
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regions located 287-bp (orexin regulatory element (OE) 1) and 2.5-kb (OE2) upstream 
of the transcription initiation site in the human prepro-orexin gene. In transgenic mice, 
both OE1 and OE2 are necessary for expressing the human prepro-orexin gene in the 
LHA and for repressing its expression in the medial regions of the hypothalamus. The 
57-bp core region of OE1 is critical for the spatial gene regulatory function of 
prepro-orexin gene in vivo, which contains crucial cis-acting elements regulating 
prepro-orexin gene expression specifically in the LHA20.  
Recently, the forkhead box transcription factor Foxa2, a downstream target of 
insulin signaling, was shown to regulate the expression of orexin22. During fasting, 
Foxa2 binds to orexin promoter to stimulate the expression. In fed and in 
hyperinsulinemic obese mice, insulin signaling leads to nuclear exclusion of Foxa2 and 
reduces expression of orexin. Constitutive activation of Foxa2 in the brain results in 
increased neuronal orexin as well as MCH expressions and increased food consumption, 
energy expenditure and insulin sensitivity. Conditional activation of Foxa2 through the 
T156A mutation also resulted in improved glucose homeostasis, decreased body fat and 
increased lean body mass. These results suggest that Foxa2 acts as a metabolic sensor in 




 1-3.Orexin Receptors 
The actions of orexins are mediated by two G-protein coupled receptors (GPCRs), 
orexin 1 and orexin 2 receptors (OX1R and OX2R, also known as Hcrtr1 and Hcrtr2).  
OX1R has one-order-of-magnitude greater affinity for orexin A over orexin B.  In 
contrast, OX2R binds both ligands with similar affinities1.  OX1R couples to Gq/11 
class of G-protein. Activation of this pathway results in activation of phospholipase C to 
trigger the phosphatidylinositol cascade and influx of extracellular Na+ and Ca2+ 
concentrations, presumably through activation of transient receptor potential (TRP) 
channels leading to depolarization of neurons.  OX2R is shown to couples to both 
Gq/11 or Gi-classes of G-proteins in a neuronal cell line23, although the physiological 
relevance of Gi-mediated pathway downstream of OX2R has not been identified.  
OX1R and OX2R exhibit a partially similar but partially distinct and basically 
complementary distribution, suggesting that these receptors have different physiological 





Orexin neurons, which have been assumed to number around 3,000 in rat brains, or 
70,000 in human brains18,25, are localized exclusively in the hypothalamus, including 
the lateral hypothalamic area (LHA), perifornical area, and posterior hypothalamus (PH) 
18,25,26. Several factors were shown to be colocalized in orexin neurons, including 
dynorphine, neuronal activity regulated rentraxin (NARP), delta-like 1 homolog 
(DLK-1), and neurotensin27. Orexin neurons also express vesicular glutamate 
transporter 2 (vGluT2), suggesting these neurons are also glutamatergic. Glutamatergic 
neurotransmission by orexin neurons was electrophysiologically demonstrated in 
tuberomammillary nucleus (TMN) histaminergic neurons using optogenetic 
stimulation28, although the physiological relevance of the capability of orexin neurons 
to elicit fast glutamatergic neurotransmission on target neurons has remained unknown.  
A number of factors that influence firing rates or membrane potential of orexin 
neurons have been identified (Table 1). Several humoral factors that are implicated in 
energy homeostasis were found to affect the activity of orexin neurons. Cholecystokinin 
(CCK-8S) and a mixture of amino acids were shown to activate orexin neurons29-32, 
whereas glucose, a BRS3 agonist and leptin inhibit them. These observations suggest 




1-5.Physiological roles of orexins 
Orexins have been recognized as multi-tasking peptides implicated in a variety of 
physiological functions, including the regulations of sleep/wakefulness states, feeding 
behavior, energy homeostasis, reward system, stress response, cognitive functions, 
emotional memory, endocrine function, thermogenesis and the autonomic nervous 
system. Among these, the most significant physiological role of orexins is thought to be 
that in the regulation of sleep/wakefulness states. This role was highlighted by the 
findings that orexin deficiency causes sleep disorder narcolepsy in humans and 
animals2-5,12. Please refer to other reviews on these functions33-35, since this review 
would focus on the role of orexins in the energy homeostasis. 
 
2. Roles of orexin in the regulation of feeding behavior 
This section discusses the role of orexins in the regulation of feeding behavior, which is 
a main focus of this review. 
2-1 Orexin and Feeding Behavior 
The role in the regulation of feeding behavior was the first described physiological 
function of orexins1. We first reported the orexigneic effect of intracerebroventricular 
administration of orexin A and orexin B in rats. This effect was validated by several 
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subsequent studies in several species33. Furthermore, antibody for orexin or an 
antagonist of OX1R was shown to decrease food intake when administered centrally36,37. 
Consistently, orexin deficient mice show significantly decreased food intake19,38. 
One of the proposed functions of the orexin system in the regulation of energy 
homeostasis is to integrate metabolic state in the wakefulness to support feeding 
behavior11,34,35. Our group showed that mice lacking orexin neurons do not show an 
increase in wakefulness or locomotor activity in response to starvation11. This suggests 
that orexin plays an important role in evoking appropriate behavior in response to 
negative energy balance. 
The first paper describing the identification of orexin had already reported that 
prepro-orexin mRNA was upregulated when animals were fasted, suggesting that orexin 
neurons sense animal’s fasting status1. Subsequently, several reports suggested that 
orexin neurons are inhibited by glucose, triglycerides, and amino acids11,32,39-41. 
Furthermore, orexin neurons are inhibited by leptin, while excited by ghrelin11. These 
observations suggest that orexin neurons are sensing these factors to monitor animals’ 
nutritional states, and integrating this information, and evoking necessary level of 
arousal.  
Orexin neurons might also directly affect neuronal circuits within the 
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hypothalamus that are implicated in the regulation of feeding behavior. Orexins were 
shown to inhibit the VMH glucoreceptor neurons, while excite the arcuate nucleus 
(ARC) NPY neurons and the LHA MCH neurons42-44. Furthermore, local application of 
orexin in the PVH, DMH, and LHA was shown to increase food intake45,46. A recent 
study showed that the area postrema and NTS are involved in the orexin mediated 
feeding47. Application of orexin A into the nucleus of accumbens shell was reported to 
increase feeding48. These studies suggest that orexin evokes feeding behavior through 
multiple pathways. 
 Orexin might also play an important role in the hedonic aspect of feeding. 
Orexin was shown to evoke motivation to feeding, especially for palatable food49-51. 
Consistently, OX1R is shown to be involved in the reward regulation by orexin52-54. 
Furthermore, the mu-opioid receptor agonist, DAMGO 
(D-Ala(2)-N-MePhe(4)-Gly-ol(5)-enkephalin) -induced feeding in the NAc shell was 
shown to be dependent on an activation of OX1R55. These observations suggest that 
orexins are involved in the regulation of feeding through multiple pathways. 
 
2-2. Roles of orexin in the regulation of body weight homeostasis 
While orexins play a role in regulating feeding behavior, they are also involved in the 
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regulation of energy expenditure, which affects body weight homeostasis. 
Narcolepsy patients were shown to have increased incidence of obesity despite 
being hypophagic, which is consistent with animal studies that showed orexin 
deficiency results in obesity in mice56. Obesity with BMI value over 30 is twice more 
common in narcolepsy patients than in general population56. Furthermore, narcoleptic 
patients were shown to be more obese than patients with idiopathic hypersomnia, 
suggesting that sleepiness and reduced activity in narcoleptic patients are not sole cause 
for the obesity56. 
Orexins have unique characteristics in feeding and energy expenditure: They 
increase feeding and energy expense simultaneously in response to various inner and 
outer environmental cues. Acute administration of orexin promotes feeding, although 
orexin deficiency in humans and mice is rather associated with obesity6,19,38,57. 
Conversely, transgenic mice with orexin overexpression show resistance to high-fat 
diet-induced obesity and insulin insensitivity58. Genetic study indicated that 
OX2R-mediated signaling predominantly mediates this effect58. Likewise, chronic 
central administration of an OX2R-agonist peptide inhibits diet-induced obesity58. 
Furthermore, orexin overexpression enhances the anorectic-catabolic effects of central 
leptin administration, while obese leptin-deficient mice are completely resistant to the 
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metabolic effects of orexin overexpression or OX2R agonist administration58. These 
observations suggest that enhanced orexin-OX2R signaling confers resistance to 
diet-induced features of the obesity and metabolic syndrome. 
 Orexins also increase insulin sensitivity through OX1R in VMH neurons, and 
enhance feeding-associated glucose utilization in skeletal muscle by increasing the 
activity of the sympathetic nervous system59. These observations suggest that orexins 
are monitoring animals’ nutritional states and appropriately control arousal and 
peripheral metabolism through the regulation of the autonomic nervous system. Orexins 
were also shown to be involved in the diet-induced thermogenic function, which is 
important to resist weight gain when animals are exposed to increased caloric load60.  
 Together, these observations suggest that in a broad sense, orexin neurons are 
involved in sensing the body’s external and internal environments, and regulate feeding 
behavior, vigilance states, and metabolic functions accordingly, which is beneficial for 
survival. 
Conclusion 
Orexins were initially shown to be involved in the regulations of feeding behavior. 
Subsequently, their roles in the regulation of sleep/wakefulness states was highlighted 
by the discovery that orexin-deficiency causes narcoleptic phenotypes in animals and 
humans. Sleep and wakefulness are regulated to occur at appropriate times that are in 
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accordance with animals’ internal and external environments. Avoiding danger and 
finding food, which are life-essential activities that are regulated by emotion, reward 
and energy balance, require vigilance and wakefulness. Orexin neurons receive 
abundant input from the limbic system14,15, which might be important for increasing 
arousal in the emotionally-relevant situations (Fig. 1). Orexin neurons are also 
regulated by peripheral metabolic cues, including ghrelin, leptin and glucose, indicating 
that orexin neurons might provide a link between energy homeostasis and vigilance 
states. Together, these observations suggest that orexin neurons are involved in sensing 
the body’s external and internal environments and regulate states of sleep and 
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Input and output of orexin neurons. Orexin neurons receive input from the limbic 
system, including the amygdala and bed nucleus of stria terminalis. These neurons also 
receive inhibitory projections from the preoptic area, a region which is thought to play 
an important role in sleep regulation. Orexin neurons are also sensing peripheral 
metabolic signals to monitor animal’s energy balance. Orexin neurons send excitatory 
projections to the arousal center in the brain stem. 
 
BF, basal forebrain; Acb, Nucleus accumbens; BST, bed nucleus of the stria terminalis; 
Amyg, amygdala; POA, preoptic area; Arc, arcuate nucleus; VTA, ventral tegmental 
area; DR, dorsal raphe; LDT, laterodorsal tegmental nucleus; LC, locus coeruleus; 
Raphe, raphe nuclei; TMN, tuberomammillary nucleus 
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